• Je něco špatně v tomto záznamu ?

Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells

A. Zmeškalová, A. Popelová, A. Exnerová, B. Železná, J. Kuneš, L. Maletínská

. 2020 ; 21 (17) : . [pub] 20200901

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012208

Grantová podpora
20-00546S Grantová Agentura České Republiky
RVO:61388963 Akademie Věd České Republiky

Prolactin-releasing peptide (PrRP), a natural ligand for the GPR10 receptor, is a neuropeptide with anorexigenic and antidiabetic properties. Due to its role in the regulation of food intake, PrRP is a potential drug for obesity treatment and associated type 2 diabetes mellitus (T2DM). Recently, the neuroprotective effects of lipidized PrRP analogs have been proven. In this study, we focused on the molecular mechanisms of action of natural PrRP31 and its lipidized analog palm11-PrRP31 in the human neuroblastoma cell line SH-SY5Y to describe their cellular signaling and possible anti-apoptotic properties. PrRP31 significantly upregulated the phosphoinositide-3 kinase-protein kinase B/Akt (PI3K-PKB/Akt) and extracellular signal-regulated kinase/cAMP response element-binding protein (ERK-CREB) signaling pathways that promote metabolic cell survival and growth. In addition, we proved via protein kinase inhibitors that activation of signaling pathways is mediated specifically by PrRP31 and its palmitoylated analog. Furthermore, the potential neuroprotective properties were studied through activation of anti-apoptotic pathways of PrRP31 and palm11-PrRP31 using the SH-SY5Y cell line and rat primary neuronal culture stressed with toxic methylglyoxal (MG). The results indicate increased viability of the cells treated with PrRP and palm11-PrRP31 and a reduced degree of apoptosis induced by MG, suggesting their potential use in the treatment of neurological disorders.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012208
003      
CZ-PrNML
005      
20210507102702.0
007      
ta
008      
210420s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms21176343 $2 doi
035    __
$a (PubMed)32882929
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Zmeškalová, Anna $u Institute of Organic Chemistry and Biochemistry, AS CR, Prague 16000, Czech Republic $u First Faculty of Medicine, Charles University, Prague 12108, Czech Republic
245    10
$a Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells / $c A. Zmeškalová, A. Popelová, A. Exnerová, B. Železná, J. Kuneš, L. Maletínská
520    9_
$a Prolactin-releasing peptide (PrRP), a natural ligand for the GPR10 receptor, is a neuropeptide with anorexigenic and antidiabetic properties. Due to its role in the regulation of food intake, PrRP is a potential drug for obesity treatment and associated type 2 diabetes mellitus (T2DM). Recently, the neuroprotective effects of lipidized PrRP analogs have been proven. In this study, we focused on the molecular mechanisms of action of natural PrRP31 and its lipidized analog palm11-PrRP31 in the human neuroblastoma cell line SH-SY5Y to describe their cellular signaling and possible anti-apoptotic properties. PrRP31 significantly upregulated the phosphoinositide-3 kinase-protein kinase B/Akt (PI3K-PKB/Akt) and extracellular signal-regulated kinase/cAMP response element-binding protein (ERK-CREB) signaling pathways that promote metabolic cell survival and growth. In addition, we proved via protein kinase inhibitors that activation of signaling pathways is mediated specifically by PrRP31 and its palmitoylated analog. Furthermore, the potential neuroprotective properties were studied through activation of anti-apoptotic pathways of PrRP31 and palm11-PrRP31 using the SH-SY5Y cell line and rat primary neuronal culture stressed with toxic methylglyoxal (MG). The results indicate increased viability of the cells treated with PrRP and palm11-PrRP31 and a reduced degree of apoptosis induced by MG, suggesting their potential use in the treatment of neurological disorders.
650    12
$a apoptóza $7 D017209
650    _2
$a proteiny regulující apoptózu $x metabolismus $7 D051017
650    _2
$a lidé $7 D006801
650    _2
$a neuroblastom $x farmakoterapie $x metabolismus $x patologie $7 D009447
650    _2
$a neuropeptidy $x chemie $x farmakologie $7 D009479
650    _2
$a neuroprotektivní látky $x chemie $x farmakologie $7 D018696
650    _2
$a hormon uvolňující prolaktin $x chemie $x farmakologie $7 D056690
650    _2
$a signální transdukce $7 D015398
650    _2
$a nádorové buňky kultivované $7 D014407
655    _2
$a časopisecké články $7 D016428
700    1_
$a Popelová, Andrea $u Institute of Organic Chemistry and Biochemistry, AS CR, Prague 16000, Czech Republic
700    1_
$a Exnerová, Aneta $u Institute of Organic Chemistry and Biochemistry, AS CR, Prague 16000, Czech Republic
700    1_
$a Železná, Blanka $u Institute of Organic Chemistry and Biochemistry, AS CR, Prague 16000, Czech Republic
700    1_
$a Kuneš, Jaroslav $u Institute of Organic Chemistry and Biochemistry, AS CR, Prague 16000, Czech Republic $u Institute of Physiology, AS CR, Prague 14200, Czech Republic
700    1_
$a Maletínská, Lenka $u Institute of Organic Chemistry and Biochemistry, AS CR, Prague 16000, Czech Republic
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 17 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32882929 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507102701 $b ABA008
999    __
$a ok $b bmc $g 1650557 $s 1132587
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 17 $e 20200901 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a 20-00546S $p Grantová Agentura České Republiky
GRA    __
$a RVO:61388963 $p Akademie Věd České Republiky
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace